Abstract
MoS2 nanosheets functionalized with poly-ethylene glycol are for the first time used as a multifunctional drug delivery system with high drug loading capacities. Using doxorubicin as the model drug and taking advantages of the strong near-infrared absorbance of MoS2, combined photothermal and chemotherapy of cancer is realized in animal experiments, achieving excellent synergistic anti-tumor effect upon systemic administration.
Keywords:
2D nanostructure; MoS2 nanosheet; combination therapy; drug delivery; photothermal therapy.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
MeSH terms
-
Animals
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / pharmacokinetics
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives
-
Camptothecin / pharmacokinetics
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Chlorophyllides
-
Combined Modality Therapy
-
Disulfides / adverse effects
-
Disulfides / chemical synthesis
-
Disulfides / chemistry*
-
Doxorubicin / administration & dosage
-
Doxorubicin / pharmacokinetics
-
Drug Carriers / adverse effects
-
Drug Carriers / chemistry*
-
Female
-
HeLa Cells
-
Humans
-
Irinotecan
-
KB Cells
-
Mammary Neoplasms, Experimental / therapy
-
Mice
-
Mice, Inbred BALB C
-
Molybdenum / adverse effects
-
Molybdenum / chemistry*
-
Nanostructures / adverse effects
-
Nanostructures / chemistry*
-
Phototherapy / methods*
-
Pilot Projects
-
Polyethylene Glycols / adverse effects
-
Polyethylene Glycols / chemical synthesis
-
Polyethylene Glycols / chemistry*
-
Porphyrins / administration & dosage
-
Porphyrins / pharmacokinetics
-
Radiation-Sensitizing Agents / administration & dosage
-
Radiation-Sensitizing Agents / pharmacokinetics
Substances
-
Antineoplastic Agents
-
Chlorophyllides
-
Disulfides
-
Drug Carriers
-
Porphyrins
-
Radiation-Sensitizing Agents
-
Polyethylene Glycols
-
phytochlorin
-
Irinotecan
-
Doxorubicin
-
Molybdenum
-
Camptothecin
-
molybdenum disulfide